Biologics in RA and Other Rheumatic Diseases

Rheumatoid Arthritis (RA) - Management - DMARDs - TNF - Rheumatology Series

Biologics in AutoImmune Ocular Disease

Rheumatoid Arthritis

Biologics Across Immune Mediated Inflammatory Disease from the Rheumatology Perspective

Selection and use of the non-anti-TNF biological therapies? Who? When? How?

Biologics and Pediatric Rheumatic Diseases

Beyond TNF Inhibitors: TB in the Age of Biologics

Initiating Biologic Therapy -- Strategies to Reduce the Risks of Complications

Therapy of RA with Non-Biologic DMARDs -- ep. 21 of 32

Management of Tuberculosis in Patients on TNF alpha Inhibitors

Preventing Infections in Patients Treated with Biologics

Anti-Drug Antibodies with Biologics (7.14.2023)

Rheumatoid (part 12) | Management (C) | Hydroxychloroquine and other Synthetic DMARDs

T Cell Targeting in Autoimmunity and Transplantation

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheumatology Perspective

Professor Angela Thomas: "Regulation of biologics & biosimilars"

When should we stop anti-TNF therapy and how do we then treat the patient?

Update in Treatment of Psoriatic Arthritis

TB in the Biologic Era